カテゴリー： Market Monitor Global, 世界, 医療/バイオ

生物製剤注射器の世界市場見通し2023年-2029年

◆英語タイトル：Biologic Injectors Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5096）

◆商品コード：MMG23JU5096
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Biologic Injectors Market 調査レポートは次の情報を含め、グローバルにおけるの生物製剤注射器市場規模と予測を収録しています。・世界の生物製剤注射器市場：売上、2018年-2023年、2024年-2029年
・世界の生物製剤注射器市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の生物製剤注射器市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「使い捨て生物製剤注射器」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

生物製剤注射器のグローバル主要企業は、BD、 Johnson & Johnson、 Roche、 Schott、 Bayer、 Nipro、 Ompi、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、生物製剤注射器のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の生物製剤注射器市場：タイプ別、2018年-2023年、2024年-2029年
世界の生物製剤注射器市場：タイプ別市場シェア、2022年
・使い捨て生物製剤注射器、再利用可能生物製剤注射器

世界の生物製剤注射器市場：用途別、2018年-2023年、2024年-2029年
世界の生物製剤注射器市場：用途別市場シェア、2022年
・病院、診療所、外来手術センター、その他

世界の生物製剤注射器市場：地域・国別、2018年-2023年、2024年-2029年
世界の生物製剤注射器市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における生物製剤注射器のグローバル売上、2018年-2023年
・主要企業における生物製剤注射器のグローバル売上シェア、2022年
・主要企業における生物製剤注射器のグローバル販売量、2018年-2023年
・主要企業における生物製剤注射器のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
BD、 Johnson & Johnson、 Roche、 Schott、 Bayer、 Nipro、 Ompi、 Novartis

*************************************************************

・調査・分析レポートの概要
生物製剤注射器市場の定義
市場セグメント
世界の生物製剤注射器市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の生物製剤注射器市場規模
世界の生物製剤注射器市場規模：2022年 VS 2029年
世界の生物製剤注射器市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの生物製剤注射器の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の生物製剤注射器製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：使い捨て生物製剤注射器、再利用可能生物製剤注射器
生物製剤注射器のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、外来手術センター、その他
生物製剤注射器の用途別グローバル売上・予測

・地域別市場分析
地域別生物製剤注射器市場規模 2022年と2029年
地域別生物製剤注射器売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
BD、 Johnson & Johnson、 Roche、 Schott、 Bayer、 Nipro、 Ompi、 Novartis
...

Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.
This report aims to provide a comprehensive presentation of the global market for Biologic Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Injectors. This report contains market size and forecasts of Biologic Injectors in global, including the following market information:
Global Biologic Injectors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biologic Injectors Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biologic Injectors companies in 2022 (%)
The global Biologic Injectors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologic Injectors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Injectors Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologic Injectors Market Segment Percentages, by Type, 2022 (%)
Disposable Biologic Injectors
Reusable Biologic Injectors
Global Biologic Injectors Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologic Injectors Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Biologic Injectors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologic Injectors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologic Injectors revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biologic Injectors revenues share in global market, 2022 (%)
Key companies Biologic Injectors sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biologic Injectors sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Johnson & Johnson
Roche
Schott
Bayer
Nipro
Ompi
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologic Injectors, market overview.
Chapter 2: Global Biologic Injectors market size in revenue and volume.
Chapter 3: Detailed analysis of Biologic Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologic Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biologic Injectors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Biologic Injectors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologic Injectors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologic Injectors Overall Market Size
2.1 Global Biologic Injectors Market Size: 2022 VS 2029
2.2 Global Biologic Injectors Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biologic Injectors Sales: 2018-2029
3 Company Landscape
3.1 Top Biologic Injectors Players in Global Market
3.2 Top Global Biologic Injectors Companies Ranked by Revenue
3.3 Global Biologic Injectors Revenue by Companies
3.4 Global Biologic Injectors Sales by Companies
3.5 Global Biologic Injectors Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biologic Injectors Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biologic Injectors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologic Injectors Players in Global Market
3.8.1 List of Global Tier 1 Biologic Injectors Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologic Injectors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biologic Injectors Market Size Markets, 2022 & 2029
4.1.2 Disposable Biologic Injectors
4.1.3 Reusable Biologic Injectors
4.2 By Type – Global Biologic Injectors Revenue & Forecasts
4.2.1 By Type – Global Biologic Injectors Revenue, 2018-2023
4.2.2 By Type – Global Biologic Injectors Revenue, 2024-2029
4.2.3 By Type – Global Biologic Injectors Revenue Market Share, 2018-2029
4.3 By Type – Global Biologic Injectors Sales & Forecasts
4.3.1 By Type – Global Biologic Injectors Sales, 2018-2023
4.3.2 By Type – Global Biologic Injectors Sales, 2024-2029
4.3.3 By Type – Global Biologic Injectors Sales Market Share, 2018-2029
4.4 By Type – Global Biologic Injectors Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biologic Injectors Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By Application – Global Biologic Injectors Revenue & Forecasts
5.2.1 By Application – Global Biologic Injectors Revenue, 2018-2023
5.2.2 By Application – Global Biologic Injectors Revenue, 2024-2029
5.2.3 By Application – Global Biologic Injectors Revenue Market Share, 2018-2029
5.3 By Application – Global Biologic Injectors Sales & Forecasts
5.3.1 By Application – Global Biologic Injectors Sales, 2018-2023
5.3.2 By Application – Global Biologic Injectors Sales, 2024-2029
5.3.3 By Application – Global Biologic Injectors Sales Market Share, 2018-2029
5.4 By Application – Global Biologic Injectors Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biologic Injectors Market Size, 2022 & 2029
6.2 By Region – Global Biologic Injectors Revenue & Forecasts
6.2.1 By Region – Global Biologic Injectors Revenue, 2018-2023
6.2.2 By Region – Global Biologic Injectors Revenue, 2024-2029
6.2.3 By Region – Global Biologic Injectors Revenue Market Share, 2018-2029
6.3 By Region – Global Biologic Injectors Sales & Forecasts
6.3.1 By Region – Global Biologic Injectors Sales, 2018-2023
6.3.2 By Region – Global Biologic Injectors Sales, 2024-2029
6.3.3 By Region – Global Biologic Injectors Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biologic Injectors Revenue, 2018-2029
6.4.2 By Country – North America Biologic Injectors Sales, 2018-2029
6.4.3 US Biologic Injectors Market Size, 2018-2029
6.4.4 Canada Biologic Injectors Market Size, 2018-2029
6.4.5 Mexico Biologic Injectors Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biologic Injectors Revenue, 2018-2029
6.5.2 By Country – Europe Biologic Injectors Sales, 2018-2029
6.5.3 Germany Biologic Injectors Market Size, 2018-2029
6.5.4 France Biologic Injectors Market Size, 2018-2029
6.5.5 U.K. Biologic Injectors Market Size, 2018-2029
6.5.6 Italy Biologic Injectors Market Size, 2018-2029
6.5.7 Russia Biologic Injectors Market Size, 2018-2029
6.5.8 Nordic Countries Biologic Injectors Market Size, 2018-2029
6.5.9 Benelux Biologic Injectors Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biologic Injectors Revenue, 2018-2029
6.6.2 By Region – Asia Biologic Injectors Sales, 2018-2029
6.6.3 China Biologic Injectors Market Size, 2018-2029
6.6.4 Japan Biologic Injectors Market Size, 2018-2029
6.6.5 South Korea Biologic Injectors Market Size, 2018-2029
6.6.6 Southeast Asia Biologic Injectors Market Size, 2018-2029
6.6.7 India Biologic Injectors Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biologic Injectors Revenue, 2018-2029
6.7.2 By Country – South America Biologic Injectors Sales, 2018-2029
6.7.3 Brazil Biologic Injectors Market Size, 2018-2029
6.7.4 Argentina Biologic Injectors Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biologic Injectors Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biologic Injectors Sales, 2018-2029
6.8.3 Turkey Biologic Injectors Market Size, 2018-2029
6.8.4 Israel Biologic Injectors Market Size, 2018-2029
6.8.5 Saudi Arabia Biologic Injectors Market Size, 2018-2029
6.8.6 UAE Biologic Injectors Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 BD
7.1.1 BD Company Summary
7.1.2 BD Business Overview
7.1.3 BD Biologic Injectors Major Product Offerings
7.1.4 BD Biologic Injectors Sales and Revenue in Global (2018-2023)
7.1.5 BD Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Biologic Injectors Major Product Offerings
7.2.4 Johnson & Johnson Biologic Injectors Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Biologic Injectors Major Product Offerings
7.3.4 Roche Biologic Injectors Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Schott
7.4.1 Schott Company Summary
7.4.2 Schott Business Overview
7.4.3 Schott Biologic Injectors Major Product Offerings
7.4.4 Schott Biologic Injectors Sales and Revenue in Global (2018-2023)
7.4.5 Schott Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Biologic Injectors Major Product Offerings
7.5.4 Bayer Biologic Injectors Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Nipro
7.6.1 Nipro Company Summary
7.6.2 Nipro Business Overview
7.6.3 Nipro Biologic Injectors Major Product Offerings
7.6.4 Nipro Biologic Injectors Sales and Revenue in Global (2018-2023)
7.6.5 Nipro Key News & Latest Developments
7.7 Ompi
7.7.1 Ompi Company Summary
7.7.2 Ompi Business Overview
7.7.3 Ompi Biologic Injectors Major Product Offerings
7.7.4 Ompi Biologic Injectors Sales and Revenue in Global (2018-2023)
7.7.5 Ompi Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Biologic Injectors Major Product Offerings
7.8.4 Novartis Biologic Injectors Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
8 Global Biologic Injectors Production Capacity, Analysis
8.1 Global Biologic Injectors Production Capacity, 2018-2029
8.2 Biologic Injectors Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologic Injectors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologic Injectors Supply Chain Analysis
10.1 Biologic Injectors Industry Value Chain
10.2 Biologic Injectors Upstream Market
10.3 Biologic Injectors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologic Injectors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biologic Injectors in Global Market
Table 2. Top Biologic Injectors Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biologic Injectors Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biologic Injectors Revenue Share by Companies, 2018-2023
Table 5. Global Biologic Injectors Sales by Companies, (K Units), 2018-2023
Table 6. Global Biologic Injectors Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biologic Injectors Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Biologic Injectors Product Type
Table 9. List of Global Tier 1 Biologic Injectors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologic Injectors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Biologic Injectors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biologic Injectors Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biologic Injectors Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biologic Injectors Sales (K Units), 2018-2023
Table 15. By Type - Global Biologic Injectors Sales (K Units), 2024-2029
Table 16. By Application – Global Biologic Injectors Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biologic Injectors Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biologic Injectors Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biologic Injectors Sales (K Units), 2018-2023
Table 20. By Application - Global Biologic Injectors Sales (K Units), 2024-2029
Table 21. By Region – Global Biologic Injectors Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biologic Injectors Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biologic Injectors Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biologic Injectors Sales (K Units), 2018-2023
Table 25. By Region - Global Biologic Injectors Sales (K Units), 2024-2029
Table 26. By Country - North America Biologic Injectors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biologic Injectors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biologic Injectors Sales, (K Units), 2018-2023
Table 29. By Country - North America Biologic Injectors Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biologic Injectors Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biologic Injectors Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biologic Injectors Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biologic Injectors Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biologic Injectors Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biologic Injectors Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biologic Injectors Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biologic Injectors Sales, (K Units), 2024-2029
Table 38. By Country - South America Biologic Injectors Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biologic Injectors Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biologic Injectors Sales, (K Units), 2018-2023
Table 41. By Country - South America Biologic Injectors Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biologic Injectors Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biologic Injectors Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biologic Injectors Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biologic Injectors Sales, (K Units), 2024-2029
Table 46. BD Company Summary
Table 47. BD Biologic Injectors Product Offerings
Table 48. BD Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. BD Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Biologic Injectors Product Offerings
Table 52. Johnson & Johnson Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Biologic Injectors Product Offerings
Table 56. Roche Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Schott Company Summary
Table 59. Schott Biologic Injectors Product Offerings
Table 60. Schott Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Schott Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Biologic Injectors Product Offerings
Table 64. Bayer Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Nipro Company Summary
Table 67. Nipro Biologic Injectors Product Offerings
Table 68. Nipro Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Nipro Key News & Latest Developments
Table 70. Ompi Company Summary
Table 71. Ompi Biologic Injectors Product Offerings
Table 72. Ompi Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Ompi Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis Biologic Injectors Product Offerings
Table 76. Novartis Biologic Injectors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novartis Key News & Latest Developments
Table 78. Biologic Injectors Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Biologic Injectors Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Biologic Injectors Production by Region, 2018-2023 (K Units)
Table 81. Global Biologic Injectors Production by Region, 2024-2029 (K Units)
Table 82. Biologic Injectors Market Opportunities & Trends in Global Market
Table 83. Biologic Injectors Market Drivers in Global Market
Table 84. Biologic Injectors Market Restraints in Global Market
Table 85. Biologic Injectors Raw Materials
Table 86. Biologic Injectors Raw Materials Suppliers in Global Market
Table 87. Typical Biologic Injectors Downstream
Table 88. Biologic Injectors Downstream Clients in Global Market
Table 89. Biologic Injectors Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biologic Injectors Segment by Type in 2022
Figure 2. Biologic Injectors Segment by Application in 2022
Figure 3. Global Biologic Injectors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biologic Injectors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biologic Injectors Revenue, 2018-2029 (US$, Mn)
Figure 7. Biologic Injectors Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologic Injectors Revenue in 2022
Figure 9. By Type - Global Biologic Injectors Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biologic Injectors Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biologic Injectors Sales Market Share, 2018-2029
Figure 12. By Type - Global Biologic Injectors Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Biologic Injectors Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biologic Injectors Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biologic Injectors Sales Market Share, 2018-2029
Figure 16. By Application - Global Biologic Injectors Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Biologic Injectors Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biologic Injectors Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biologic Injectors Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biologic Injectors Sales Market Share, 2018-2029
Figure 21. By Country - North America Biologic Injectors Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biologic Injectors Sales Market Share, 2018-2029
Figure 23. US Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biologic Injectors Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biologic Injectors Sales Market Share, 2018-2029
Figure 28. Germany Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 29. France Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biologic Injectors Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biologic Injectors Sales Market Share, 2018-2029
Figure 37. China Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 41. India Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biologic Injectors Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biologic Injectors Sales Market Share, 2018-2029
Figure 44. Brazil Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biologic Injectors Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biologic Injectors Sales Market Share, 2018-2029
Figure 48. Turkey Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biologic Injectors Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biologic Injectors Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biologic Injectors by Region, 2022 VS 2029
Figure 54. Biologic Injectors Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生物製剤注射器の世界市場見通し2023年-2029年(Biologic Injectors Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

生物製剤注射器の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp